The effectiveness of combined treatment of rosacea using neodymium laser and photodynamic therapy

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The treatment of patients with rosacea presents a problem due to the lack of effectiveness of available therapeutic agents and methods, the need to use them for a long time and possible poor tolerance. The combined use of a vascular laser and photodynamic therapy, which has anti-inflammatory and antimicrobial effects, may be a promising direction in the treatment of patients suffering from the papulopustular subtype of this pathology. Objective. Evaluation of the efficacy and safety of combined treatment of patients with papulopustular subtype of rosacea using a neodymium laser and photodynamic therapy. Methods. 35 patients with papulopustular subtype of rosacea were followed-up. In the complex of therapeutic measures, laser therapy using a neodymium laser DEKA Motus AY (2 procedures) and photodynamic therapy REVIXAN with a photosensitizer chlorin E6 were consistently used (5 procedures per course). In dynamics, the number of inflammatory elements (papules, pustules), IGA index, der-matological life quality index DLQI, and side effects of therapy were evaluated. Results. In patients receiving laser therapy and photodynamic therapy, compared with the control group receiving topical therapy with metronidazole, a decrease in the key manifestations of the disease (the severity of background centrofacial erythema; the number and size of inflammatory papules and pustules) was noted at an earlier time. Serious side effects of the therapy were not registered. Conclusion. Thus, the use of instrumentsl methods of therapy for rosacea significantly improves the results of therapy for this disease in patients in the form of a significant decrease in the severity of centrofacial permanent erythema, the number and size of inflammatory papules and pustules.

Full Text

Restricted Access

About the authors

Andrey L. Bakulev

Central State Medical Academy of the Administrative Department of the President of the Russian Federation

Email: al_ba05@mail.ru
Dr. Sci. (Med.), Professor, Professor at the Department of Dermatovenereology and Cosmetology Moscow, Russia

M. V Bakuleva

SB Clinic Cosmetology

Saratov, Russia

References

  1. Reinholz M., Tietze J.K., Kilian Ky., et al. Rosacea - S1 guideline. J Dtsch Dermatol Ges. 2013;11(8):768-80; 768-79. Doi: 10.1111/ ddg.12101
  2. Клинические рекомендации. Розацеа. Российское общество дерматовенерологов и косметологов, 2020 г
  3. Wilkin J, Dahl M., Detmar M., et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-87. Doi: 10.1067/ mjd.2002.120625.
  4. Tan J., Schofer H., Araviiskaia E., et al. RISE study group. Prevalence of rosacea in the general population of Germany and Russia -The RISE study. J Eur Acad Dermato. Venereol. 2016;30(3):428-34. doi: 10.1111/jdv.13556.
  5. Акне и розацеа. Под ред. Л.С. Кругловой. М., 2021. 207 с.
  6. Palatsi R., KelhаЁlаЁ H.-L., HаЁgg P. New insights in the pathogenesis and treatment of rosacea. Duodecim. 2012;128:2327-35.
  7. Yamasaki K., Kanada K., Macleod D.T, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol Soc Invest Dermatol Inc. 2011;131(3):688-97. doi: 10.1038/jid.2010.351.
  8. Steinhoff M., Buddenkotte J., Aubert J., et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2-11. Doi: 10.1038/ jidsymp.2011.7.
  9. Darlenski R., Kazandjieva J., Tsankov N., et al. Acute irritant threshold correlates with barrier function, skin hydration and contact hypersensitivity in atopic dermatitis and rosacea. Exp Dermatol. 2013;22:752-53. doi: 10.1111/exd.12251.
  10. Meyer-Hoffert U., SchrоЁder J.-M. Epidermal Proteases in the Pathogenesis of Rosacea. J Investig Dermatol Symp Proc. 2011;15:16-23. doi: 10.1038/jidsymp.2011.2.
  11. Voegeli R., Rawlings A.V., Doppler S., et al. Increased basal transepidermal water loss leads to elevation of some but not all stratum corneum serine proteases.Int J Cosmet. Sci. 2008;30:435-42. doi: 10.1111/j.1468-2494.2008.00472.x.
  12. Потекаев Н.Н., Круглова Л.С. Лазер в дерматологии и косметологии. М. 2015. 289 с.
  13. Webster G., Schaller M., Tan J., et al. Defining treatment success in rosacea as ‘clear' may provide multiple patient benefits: results of a pooled analysis. J Dermatol Treat. 2017;28(5):469-74. doi: 10.1080/09546634.2017.1343435.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies